Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Akebia Therapeutics (AKBA) Tax Provisions (2018 - 2025)

Akebia Therapeutics (AKBA) has disclosed Tax Provisions for 3 consecutive years, with $615000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Tax Provisions changed N/A to $615000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $615000.0, a N/A change, with the full-year FY2025 number at $1.6 million, changed N/A from a year prior.
  • Tax Provisions was $615000.0 for Q3 2025 at Akebia Therapeutics, up from -$1.8 million in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $615000.0 in Q3 2025 to a low of $615000.0 in Q3 2025.